Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial

Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis

(2019) Yusuke Sakaguchi et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Increased mortality in haemodialysis patients administered high doses of erythropoiesis-stimulating agents: a propensity score-matched analysis

(2017) Rafael Pérez-García et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Hemodialysis Facility Variation in Hospitalization and Transfusions Using Medicare Claims: The DOPPS Practice Monitor for US Dialysis Care

(2016) Douglas S. Fuller et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Mortality and Cardiovascular Morbidity Associated with Haemoglobin Levels: A Pooled Analysis of Randomised Controlled Trials

(2015) Francesco Locatelli et al.   NEPHRON CLINICAL PRACTICE

Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement

(2013) Francesco Locatelli et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

C.E.R.A. safety profile: a pooled analysis in patients with chronic kidney disease

(2011) F. Locatelli et al.   CLINICAL NEPHROLOGY

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

(2009) Marc A. Pfeffer et al.   NEW ENGLAND JOURNAL OF MEDICINE